Home/Filings/4/0000914190-15-000322
4//SEC Filing

Cardiovascular Systems Inc 4

Accession 0000914190-15-000322

CIK 0001180145operating

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 4:43 PM ET

Size

14.1 KB

Accession

0000914190-15-000322

Insider Transaction Report

Form 4
Period: 2015-08-10
Martin David
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2015-08-10+56,036423,454 total
  • Award

    Common Stock

    2015-08-10+56,036479,490 total
  • Award

    Common Stock

    2015-08-10+37,358516,848 total
Holdings
  • Common Stock

    (indirect: By Children)
    850
  • Stock Option (right to buy)

    Exercise: $7.90Exp: 2017-06-11Common Stock (90,580 underlying)
    90,580
  • Common Stock

    (indirect: By Children)
    850
  • Common Stock

    (indirect: By Children)
    350
  • Stock Option (right to buy)

    Exercise: $8.75Exp: 2019-03-01Common Stock (32,350 underlying)
    32,350
  • Stock Option (right to buy)

    Exercise: $12.15Exp: 2017-12-11Common Stock (234,395 underlying)
    234,395
Footnotes (4)
  • [F1]Subject to performance-based forfeiture based on total shareholder return for fiscal 2016 versus the Company's peer group.
  • [F2]Subject to performance-based forfeiture based on annual revenue growth for fiscal 2016 versus the Company's peer group.
  • [F3]Restrictions lapse as to 12,453 shares on 8/13/16 and 8/13/17 and 12,452 shares on 8/13/18.
  • [F4]Fully exercisable.

Issuer

Cardiovascular Systems Inc

CIK 0001180145

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001180145

Filing Metadata

Form type
4
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:43 PM ET
Size
14.1 KB